Cite
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
MLA
Jody Vykoukal, et al. “Caveolin-1-Mediated Sphingolipid Oncometabolism Underlies a Metabolic Vulnerability of Prostate Cancer.” Nature Communications, vol. 11, no. 1, Aug. 2020, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41467-020-17645-z.
APA
Jody Vykoukal, Johannes F. Fahrmann, Justin R. Gregg, Zhe Tang, Spyridon Basourakos, Ehsan Irajizad, Sanghee Park, Guang Yang, Chad J. Creighton, Alia Fleury, Jeffrey Mayo, Adriana Paulucci-Holthauzen, Jennifer B. Dennison, Eunice Murage, Christine B. Peterson, John W. Davis, Jeri Kim, Samir Hanash, & Timothy C. Thompson. (2020). Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nature Communications, 11(1), 1–16. https://doi.org/10.1038/s41467-020-17645-z
Chicago
Jody Vykoukal, Johannes F. Fahrmann, Justin R. Gregg, Zhe Tang, Spyridon Basourakos, Ehsan Irajizad, Sanghee Park, et al. 2020. “Caveolin-1-Mediated Sphingolipid Oncometabolism Underlies a Metabolic Vulnerability of Prostate Cancer.” Nature Communications 11 (1): 1–16. doi:10.1038/s41467-020-17645-z.